Johnson & Johnson (JNJ) reported strong second - quarter profit and revenue before the opening bell Thursday, with better-than-expected results both domestically and internationally, as well as across all major operating segments.
It's possible that J & J management will offer up Kenvue shares at a discount to market value.
Regardless, arbitrage isn't our game and we want to be invested in J & J for the long term.
The only change — since J & J owns 89.6% of Kenvue — is that 10.4% of earnings generated since Kevnue went public in early May to the end of the quarter are no longer attributed to J & J.
A Johnson & Johnson building is shown in Irvine, California.
Persons:
Johnson, —, Kevnue, J, J's, prioritization, Jim Cramer's, Jim Cramer, Jim, Mike Blake
Organizations:
Dow, Pharmaceutical, Management, J's, Johnson, J, Consumer, Consumer Health, Pharmaceutical Pharmaceutical, CNBC, & $
Locations:
Kenvue, JNJ, KVUE, Spravato, Irvine , California